1. A review of the stability and compatibility of antineoplastic drugs for multiple-drug infusions

   • David A. Williams
   • Jacob Lokich

   Review Pages: 171 - 181

2. The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer

   • Minoru Takada
   • Masahiro Fukuoka
   • Hidehiko Yamamoto

   Original Articles Pages: 182 - 186

3. Phase II study ofcis-diammine(glycolato)platinum, 254-S, in patients with advanced germ-cell testicular cancer, prostatic cancer, and transitional-cell carcinoma of the urinary tract

   • Hideyuki Akaza
   • Masaki Togashi
   • 254-S Urological Cancer Study Group

   Original Articles Pages: 187 - 192

4. Inhibition of fludarabine metabolism by arabinosylcytosine during therapy

   • Annette Kemena
   • Varsha Gandhi
   • William Plunkett

   Original Articles Pages: 193 - 199

5. Prevention of doxorubicin-induced myocardial and haematological toxicities in rats by the iron chelator desferrioxamine

   • M. M. Al-Harbi
   • Naji M. Al-Gharably
   • Hassan N. Tawfik

   Original Articles Pages: 200 - 204

6. Identification of metabolites of the antitumor agentd-limonene capable of inhibiting protein isoprenylation and cell growth

   • Pamela L. Crowell
   • Shouzhong Lin
   • Michael N. Gould

   Original Articles Pages: 205 - 212

7. Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer

   • Walter M. Stadler
   • Nicholas J. Vogelzang
   • Greg Whitman

   Original Articles Pages: 213 - 216

8. Red blood cell methotrexate and folate levels in children with acute lymphoblastic leukemia undergoing therapy: a Pediatric Oncology Group pilot study

   • Michael L. Graham
   • Jonathan J. Shuster
   • V. Michael Whitehead

   Original Articles Pages: 217 - 222

9. Inhibition of growth factor binding, Ca²⁺ signaling and cell growth by polysulfonated azo dyes related to the antitumor agent suramin

   • G. Powis
   • M. J. Seewald
   • D. E. Chapman

   Original Articles Pages: 223 - 228

10. Evaluation of 9-dimethylaminomethyl-10-hydroxycamptothecin against xenografts derived from adult and childhood solid tumors

    • Peter J. Houghton
    • Pamela J. Cheshire
    • Janet A. Houghton

    Original Articles Pages: 229 - 239

11. In vivo depletion of O⁶-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue

    • Siow Ming Lee
    • Nick Thatcher
    • Geoffrey P Margison

    Original Articles Pages: 240 - 246

12. Choice of starting dose and escalation for phase I studies of antitumor agents

    • John S. Penta
    • Gary L. Rosner
    • Donald L. Trump

    Original Articles Pages: 247 - 250

13. Pharmacokinetics and efficacy of rectal versus oral sustained-release morphine in cancer patients

    • Timothy J. Wilkinson
    • Bridget A. Robinson
    • Jennifer J. Schnieder

    Original Articles Pages: 251 - 254

14. Cross-resistance of drug-resistant murine P388 leukemias to toxol in vivo

    • William R. Waud
    • Karen S. Gilbert
    • Daniel P. Griswold Jr.

    Short Communication Pages: 255 - 257

15. International Union Against Cancer Union Internationale Contre Le Cancer Fellowships

    Announcement Pages: 258 - 258